Recently Published

At the 2024 SIR Meeting in Salt Lake City, Utah, interventional radiologist Mark Lessne, MD, from Vascular & Interventional Specialists, Charlotte Radiology in Charlotte, North Carolina, presented several sessions, including “Beyond Paclitaxel: A Review of Non-Paclitaxel-Based Antiproliferative Therapies for PAD Management.” We spoke with Dr. Lessne about his presentation and the future of PAD management.

At the 2024 SIR Meeting in Salt Lake City, Utah, Waseem Wahood, MD, MS, from HCA Florida Aventura Hospital, Aventura, Florida, presented results from a study that analyzed 30-day perioperative outcomes from the National Surgical Quality Improvement Project (NSQIP) in patients who received intervention for chronic limb-threatening ischemia (CLTI). We spoke with Dr. Wahood about his study and what the results could mean for patients with CLTI.

Watch as Dr. Thomas Zeller reviews his presentation on the treatment of symptomatic femoropopliteal disease with drug-coated balloons vs bare-metal stents, which he gave at the Amputation Prevention Symposium in August 2023. 

Watch as Barry Katzen, MD, provides an update on what's new with the CLI Global Society and the Journal of Critical Limb Ischemia.

Dr Pliagas discusses his retrospective study, recently published in JCLI, in which he and his co-investigators sought to demonstrate safety and performance of the Terumo Glidesheath Slender for tibiopedal access. Initially, tibiopedal access was considered a very experimental technique, but over the past few years, Dr Pliagas and his colleagues have learned to routinely gain access to vessels from below, using this technique.

Drs Driver and Neville discuss the crucial component of podiatry in the multidisciplinary treatment of CLTI.

Dr John H Rundback discusses his recent JCLI article, "Patterns of Failure in Deep Venous Arterialization and Implications for Management."

Daniel Clair, MD, Chair of Vascular Surgery from Vanderbilt University Medical Center discusses a number of interesting findings discovered during the BEST CLI trial.

The CLI Global Society was formed in 2016 to improve patient quality of life by preventing amputations and death due to CLI. Barry Katzen, MD, President of the CLI Global Society, discusses the society's mission and the role of the Journal of Critical Limb Ischemia in achieving its goals.

Study co-author George Adams, MD, offers further insight into the topic in the video commentary below.